Editors Overview

tdd maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Open Access
Special Issue
Topic

Applications of Nanotechnology in Drug Delivery to the peripheral nervous system

Abstract Submission Deadline : November 30, 2024

Manuscript Submission Deadline : December 25, 2024

Special Issue Description

New nanotechnology tactics to enhance drug delivery to the Peripheral nervous system have drawn increasing attention from academics and drug designers in recent years (PNS). The treatment of neurological conditions, including Alzheimer’s disease, Parkinson’s disease, brain tumors, and stroke, has a significant deal of potential to be impacted by nanotechnology. Numerous investigations on the topic of neurodegeneration revealed that CNS illnesses have been successfully treated with nanomaterials. Nanocarriers have made it possible to transport chemotherapeutics to specific locations, which has effectively slowed the growth of malignant brain tumors. The treatment of PNS diseases, which improves the overall effect of medication and emphasizes the significance of nano-therapeutics, is thus the most effective application of nanomaterials. To transport therapeutic agents to the CNS, this study was done to analyze the data on the use of nanotechnology in the design of drug delivery systems that can pass through the blood-brain barrier (BBB).

Keywords

Nanotechnology, Peripheral nervous system, blood-brain barrier, Lipophilic analogs

Manuscript Submission information

Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.

Participating journals:


2394-7268

Journal Name

Trends in Drug Delivery

Abbrivation


tdd

ISSN


2394-7268

Since

2014

APC

950  $